Fisher Asset Management
EW icon

Fisher Asset Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$24.7M Sell
316,392
-9,784,074
-97% -$765M 0.01% 292
2025
Q1
$732M Buy
10,100,466
+325,190
+3% +$23.6M 0.32% 85
2024
Q4
$724M Buy
9,775,276
+696,965
+8% +$51.6M 0.29% 78
2024
Q3
$599M Buy
9,078,311
+806,705
+10% +$53.2M 0.25% 89
2024
Q2
$764M Buy
8,271,606
+644,728
+8% +$59.6M 0.33% 79
2024
Q1
$729M Buy
7,626,878
+498,599
+7% +$47.6M 0.34% 79
2023
Q4
$544M Sell
7,128,279
-186,188
-3% -$14.2M 0.29% 90
2023
Q3
$507M Sell
7,314,467
-703,324
-9% -$48.7M 0.29% 95
2023
Q2
$756M Buy
8,017,791
+198,252
+3% +$18.7M 0.42% 73
2023
Q1
$647M Buy
7,819,539
+146,921
+2% +$12.2M 0.39% 82
2022
Q4
$572M Buy
7,672,618
+133,880
+2% +$9.99M 0.39% 80
2022
Q3
$623M Buy
7,538,738
+208,057
+3% +$17.2M 0.47% 66
2022
Q2
$697M Buy
7,330,681
+227,736
+3% +$21.7M 0.49% 63
2022
Q1
$836M Buy
7,102,945
+320,643
+5% +$37.7M 0.49% 63
2021
Q4
$879M Buy
6,782,302
+357,605
+6% +$46.3M 0.49% 52
2021
Q3
$727M Buy
6,424,697
+267,356
+4% +$30.3M 0.45% 64
2021
Q2
$638M Buy
6,157,341
+334,627
+6% +$34.7M 0.4% 66
2021
Q1
$487M Buy
5,822,714
+244,081
+4% +$20.4M 0.34% 74
2020
Q4
$509M Buy
5,578,633
+386,233
+7% +$35.2M 0.38% 67
2020
Q3
$414M Buy
5,192,400
+204,982
+4% +$16.4M 0.36% 64
2020
Q2
$345M Buy
4,987,418
+3,632,715
+268% +$251M 0.34% 71
2020
Q1
$256M Buy
1,354,703
+1,346,783
+17,005% +$254M 0.32% 72
2019
Q4
$1.85M Sell
7,920
-1,346
-15% -$314K ﹤0.01% 502
2019
Q3
$2.04M Buy
9,266
+2,141
+30% +$471K ﹤0.01% 532
2019
Q2
$1.32M Buy
+7,125
New +$1.32M ﹤0.01% 584